Enalaprilat and losartan decrease erythroid precursors frequency in cells from patients with polycythemia vera.
Sign Up to like & getrecommendations! Published in 2023 at "Hematology"
DOI: 10.1080/16078454.2023.2182056
Abstract: OBJECTIVE Polycythemia Vera (PV) is a myeloproliferative neoplasm characterized by the overproduction of red blood cells. First-line therapies are directed at lowering hematocrit levels. After the discovery of a mutation in the Janus kinase 2… read more here.
Keywords: erythrocytosis; enalaprilat losartan; decrease erythroid; jak2 ... See more keywords